日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Real-World Outcomes of Primary Versus Interval Debulking Surgery in a Multicenter Cohort of Advanced Ovarian Cancer Patients Treated with Bevacizumab

在接受贝伐单抗治疗的晚期卵巢癌患者多中心队列研究中,初次肿瘤细胞减灭术与间隔性肿瘤细胞减灭术的真实世界疗效

Michalczyk, Kaja; Bodnar, Lubomir; Czeluścińska-Murawiec, Marta; Dańska-Bidzińska, Anna; Derlatka, Paweł; Maćkowiak-Matejczyk, Beata; Sawczuk, Wioleta; Radecka, Barbara; Operacz, Edyta; Piątek, Szymon; Kalinka, Ewa; Miller, Adam; Chudecka-Głaz, Anita

Evaluating tumor chemosensitivity: a head-to-head comparison of the prognostic value of KELIM (modeled CA125 elimination rate constant K) and RECIST 1.1 (radiological response valuation criteria in solid tumors) in ovarian cancer

评估肿瘤化疗敏感性:KELIM(模拟CA125消除速率常数K)和RECIST 1.1(实体瘤放射学反应评估标准)在卵巢癌预后价值方面的直接比较

Michalczyk, Kaja; Mokrzycka, Agata; Rudzińska, Marianna; Misiek, Marcin; Chudecka-Głaz, Anita

Moving together to facilitate equity and inclusion in research. The co-production of interventions for clinical trials to facilitate participation of people from ethnically diverse communities

携手促进研究中的公平性和包容性。共同制定临床试验干预措施,以促进来自不同族裔社区的人们参与。

Ramage, Emily R; Sharma, Hannah; Batchelor, Frances; Bicknell, Erin; Bongiovanni, Lyn; Brijnath, Bianca; Cahill, Priyanka; Callisaya, Michele; Chudecka, Agnieszka; Cursio-Barcham, Rosa; Engel, Lidia; Klaic, Marlena; Lam, Eleanor; Lim, Wen Kwang; McDonald, Cassie E; Pinheiro, Marina B; Sherrington, Catherine; Vogrin, Sara; Zanker, Jesse; Zheng, Cheng; Said, Catherine M

Corrigendum: Blood biomarker dynamics in people with relapsing multiple sclerosis treated with cladribine tablets: results of the 2-year MAGNIFY-MS study

更正:克拉屈滨片剂治疗复发型多发性硬化症患者的血液生物标志物动态变化:为期两年的 MAGNIFY-MS 研究结果

Wiendl, Heinz; Barkhof, Frederik; Montalban, Xavier; Achiron, Anat; Derfuss, Tobias; Chan, Andrew; Hodgkinson, Suzanne; Prat, Alexandre; Leocani, Letizia; Schmierer, Klaus; Sellebjerg, Finn; Vermersch, Patrick; Jin, Hulin; Chudecka, Anita; Kloetgen, Andreas; Lin, Dongdong; Gardner, Lidia; De Stefano, Nicola

Blood biomarker dynamics in people with relapsing multiple sclerosis treated with cladribine tablets: results of the 2-year MAGNIFY-MS study

克拉屈滨片剂治疗复发型多发性硬化症患者的血液生物标志物动态变化:为期2年的MAGNIFY-MS研究结果

Wiendl, Heinz; Barkhof, Frederik; Montalban, Xavier; Achiron, Anat; Derfuss, Tobias; Chan, Andrew; Hodgkinson, Suzanne; Prat, Alexandre; Leocani, Letizia; Schmierer, Klaus; Sellebjerg, Finn; Vermersch, Patrick; Jin, Hulin; Chudecka, Anita; Kloetgen, Andreas; Lin, Dongdong; Gardner, Lidia; De Stefano, Nicola

Summary of Research: Blood Biomarker Dynamics in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Results of the 2-Year MAGNIFY-MS Study

研究概要:克拉屈滨片治疗复发型多发性硬化症患者的血液生物标志物动态变化:为期两年的 MAGNIFY-MS 研究结果

Wiendl, Heinz; Barkhof, Frederik; Montalban, Xavier; Achiron, Anat; Derfuss, Tobias; Chan, Andrew; Hodgkinson, Suzanne; Prat, Alexandre; Leocani, Letizia; Schmierer, Klaus; Sellebjerg, Finn; Vermersch, Patrick; Jin, Hulin; Chudecka, Anita; Kloetgen, Andreas; Lin, Dongdong; Gardner, Lidia; De Stefano, Nicola

Clinical and mechanistic effects of cladribine in relapsing multiple sclerosis: 2-year results from the MAGNIFY-MS Study

克拉屈滨治疗复发型多发性硬化症的临床和机制效应:MAGNIFY-MS 研究的 2 年结果

Schmierer, Klaus; Wiendl, Heinz; Barkhof, Frederik; Montalban, Xavier; Achiron, Anat; Derfuss, Tobias; Chan, Andrew; Hodgkinson, Suzanne; Prat, Alexandre; Leocani, Letizia; Sellebjerg, Finn; Vermersch, Patrick; Jin, Hulin; Sponton, Laura; Chudecka, Anita; Gardner, Lidia; De Stefano, Nicola

Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysis

根据肿瘤性激素受体表达情况评估卵巢癌风险和生存率:卵巢癌协会联盟和卵巢肿瘤组织分析联盟的汇总分析

Fu, Zhuxuan; Borho, Lauren; Taylor, Sarah E; Kelemen, Linda E; DeFazio, Anna; Webb, Penelope M; Köbel, Martin; Meagher, Nicola S; Na, Renhua; Antoniou, Antonis C; Brand, Alison H; Kennedy, Catherine J; Nevins, Nikilyn; Pharoah, Paul D P; Shvetsov, Yurii B; Winham, Stacey J; Alsop, Jennifer; Beckmann, Matthias W; Bolithon, Adelyn; Boros, Jessica; Bowtell, David D L; Brenton, James D; Carney, Michael E; Chudecka-Głaz, Anita; Cook, Linda S; Cybulski, Cezary; Fasching, Peter A; Fereday, Sian; Fortner, Renée T; García, María J; Goode, Ellen L; Goodman, Marc T; Gronwald, Jacek; Hartmann, Arndt; Hernandez, Brenda Y; Høgdall, Estrid; Huntsman, David G; Jensen, Allan; Jimenez-Linan, Mercedes; Joseph, Janine M; Karlan, Beth Y; Kaznowska, Ewa; Kjaer, Susanne K; Kluz, Tomasz; Koziak, Jennifer M; Lester, Jenny; Longacre, Teri A; Lycke, Maria; McGuire, Valerie; Moysich, Kirsten B; Murphy, Rachel A; Orsulic, Sandra; Ramus, Susan J; Rodríguez-Antona, Cristina; Rothstein, Joseph H; Samra, Spinder; Sieh, Weiva; Steed, Helen; Sundfeldt, Karin; Talhouk, Aline; Uciński, Jan; Wang, Chen; Wentzensen, Nicolas; Whittemore, Alice S; Wilkens, Lynne R; Songer, Thomas; Brooks, Maria Mori; Tang, Lu; Modugno, Francesmary

The influence of genetic factors on the severity of anxiety and depressive symptoms and the choice of coping strategies in reproductive tract cancer-a preliminary study

遗传因素对生殖道癌症患者焦虑和抑郁症状严重程度及应对策略选择的影响——一项初步研究

Jurczak, Anna; Chudecka-Głaz, Anita; Michalczyk, Anna; Ćwiek, Dorota; Owsianowska, Joanna; Wieder-Huszla, Sylwia

Updated Guidelines for the Diagnosis and Treatment of Endometrial Carcinoma: The Polish Society of Gynecological Oncology (2025v)

更新的子宫内膜癌诊断和治疗指南:波兰妇科肿瘤学会(2025v)

Sznurkowski, Jacek J; Bodnar, Lubomir; Dańska-Bidzińska, Anna; Marszałek, Andrzej; Blecharz, Pawel; Chudecka-Głaz, Anita; Klasa-Mazurkiewicz, Dagmara; Kowalik, Artur; Zołciak-Siwinska, Agnieszka; Zielinska, Aleksandra; Bidziński, Mariusz; Sawicki, Włodzimierz